Gilead Sciences completes purchase of MYR GmbH for 1.45 billion Euros Ruchika Sharma7 March 2021 10:00 AM ISTFoster City: Gilead Sciences, Inc. has recently announced the completion of the previously announced transaction to acquire MYR GmbH for up to...
Gilead remdesivir not associated with kidney problems in COVID-19 patients: European panel Ruchika Sharma14 Feb 2021 10:00 AM ISTNew Delhi: Europe's drugs regulator said on Friday its safety panel found no evidence that Gilead's remdesivir caused kidney problems in some COVID-19...
Mexico will not follow USFDA in approving Gilead COVID-19 drug: Report Ruchika Sharma25 Oct 2020 10:15 AM ISTMexico City: Mexico will not necessarily follow the U.S. Food and Drug Administration (FDA) in approving Gilead Science Inc's antiviral drug...
Gilead contests WHO study claiming Covid drug Remdesivir Failed to Reduce Mortality Ruchika Sharma17 Oct 2020 9:30 AM ISTUS: Gilead Sciences Inc has questioned the findings of a World Health Organization (WHO) study that concluded its Covid-19 drug remdesivir does not...
Gilead, European Commission ink pact for 500000 treatment courses of Remdesivir against COVID-19 MD Bureau10 Oct 2020 10:00 AM ISTAt this stage, Remdesivir is the only medicine with a conditional marketing authorisation in the EU for the treatment of COVID-19 patients needing...
Gilead to acquire Immunomedics for over USD 20 billion Ruchika Sharma14 Sept 2020 4:25 PM ISTUS: Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than $20 billion in a deal that would...
Pfizer teams up with Gilead to help manufacture Covid drug remdesivir Ruchika Sharma10 Aug 2020 12:38 PM ISTUS: Pfizer Inc (PFE.N) said on Friday it signed a multiyear agreement to make COVID-19 treatment remdesivir for developer Gilead Sciences Inc...
COVID-19: One in three South Korean patients showed improvement with Remdesivir Ruchika Sharma14 July 2020 10:45 AM ISTNine of the patients showed an improvement in their condition, 15 showed no change, and three worsened, KCDC deputy director Kwon Jun-wook told a...
Remdesivir reduced risk of death in Covid-19 patients, more studies needed: Gilead Ruchika Sharma12 July 2020 10:15 AM ISTGilead said it analyzed data from 312 patients treated in a late-stage study and a separate real-world retrospective cohort of 818 patients with...
Gilead Sciences condemned for pricing coronavirus drug at USD 2340 Ruchika Sharma30 Jun 2020 10:45 AM ISTBut recent news that a cheap steroid called dexamethasone improves survival means remdesivir should be priced between USD 2,520 and USD 2,800, the...
Zydus Cadila, Gilead ink licensing agreement to manufacture, market Remdesivir Ruchika Sharma13 Jun 2020 11:25 AM ISTUnder the agreement, the license is royalty-free until another pharmaceutical product or vaccine is approved for the treatment or prevention of COVID...
